Clinical Trial Update: Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing pegaptanib sodium to sham injection in diabetic macular edema involving the center of the macula; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Pegaptanib (Pegaptanib sodium)

Snippet

Sponsor: Eyetech Pharmaceuticals | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED